Think the U.S. stock market is too heavily exposed to AI? It’s even worse abroad.

The article warns that AI-driven concentration risk may be worse outside the U.S., noting that in many foreign markets a handful of stocks account for a larger share of market capitalization than in the U.S. Overall, it flags portfolio concentration as a key cross-market risk tied to the continued dominance of AI-related equities, but provides no specific earnings, policy, or index moves.

Analysis

The key market implication is that “diversification” is becoming a mislabel in cap-weighted international benchmarks: a small set of mega-caps is increasingly doing the index’s heavy lifting, so allocators who moved abroad for balance may have simply swapped one concentration risk for another. That matters because these names tend to trade on the same global liquidity and duration-sensitive factor set, which means an AI multiple reset can propagate through U.S. and ex-U.S. indices at the same time rather than being offset by local breadth.

The second-order loser is passive international exposure, especially broad EAFE/ACWI ex-U.S. vehicles where index-level upside is hostage to a handful of high-beta leaders. The relative winner is active managers and equal-weight strategies that can harvest dispersion as headline benchmarks get more fragile; in a market like this, stock selection has a higher chance of beating “beta” than usual because the beta itself is increasingly synthetic.

Near term, the catalyst path is less about macro and more about breadth data, earnings revisions, and any pause in AI capex enthusiasm over the next 1-3 months. The contrarian takeaway is that the crowd may be underestimating how little safety there is in going overseas: if the AI trade de-rates, foreign indices may not cushion the blow, and if it stays hot, their concentration still leaves limited participation. The thesis is falsified if ex-U.S. earnings breadth improves materially or if cap-weighted international indices start outperforming on wider participation rather than just a few names.

Key Decisions for Investors

• Prefer active or equal-weight ex-U.S. exposure over cap-weighted EFA/IEFA for new allocations over the next 1-3 months; the payoff is better diversification if breadth remains narrow, and the main risk is missing a broadening rally.
• Pair trade: short EFA or VEU versus long a diversified U.S. equal-weight basket like RSP on any AI-led volatility spike; this expresses the view that foreign benchmarks are less defensive than they look. Stop if ex-U.S. breadth materially improves for 2 consecutive earnings cycles.
• If maintaining foreign beta, size passive ex-U.S. index exposure 20-30% below neutral and redeploy the rest into active country/sector sleeves; this is a risk-management move, not a conviction short.
• Buy 3-month EFA puts only if MSCI ex-U.S. breadth rolls over again and AI leaders weaken simultaneously; the setup works best as defined-risk protection against a concentration unwind, not as a standalone directional bet.
• Watch the spread between cap-weighted and equal-weight ex-U.S. performance as the key signal; if the equal-weight line stops outperforming, the concentration thesis is fading and the trade should be reduced.